Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc., trading under the ticker HSAQ, originated as Health Assurance Acquisition Corp, a blank-check company sponsored by Health Assurance Equity Partners and backed by General Atlantic, that completed its IPO in 2020 with a focus on the healthcare technology sector. The SPAC subsequently pursued a business combination with Orchestra BioMed, a bioelectronic medicine and cardiovascular medical device company known for its BackBeat CNT hypertension therapy program. The October 2022 Form 8-K filing reflects activity during the de-SPAC process as the combined entity, Orchestra BioMed Holdings, Inc., progressed toward completing its merger. The company operates at the intersection of medical devices and neuromodulation, targeting cardiometabolic disease. Sign up on SpacDesk for the full filing history, deal timeline, and sponsor data on HSAQ and hundreds of other SPACs.